Search Result "pembrolizumab."
Review of the Clinical Pharmacokinetics, Efficacy and Safety of Pembrolizumab
Journal: Current Drug Metabolism
Volume: 23 Issue: 6 Year: 2022 Page: 460-472
Author(s):
Pembrolizumab-Induced Seronegative Arthritis and Fasciitis in a Patient with Lung Adenocarcinoma
Journal: Current Drug Safety
Volume: 14 Issue: 3 Year: 2019 Page: 225-229
Author(s): Senol Kobak
Pembrolizumab for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: Analysis of Prognostic Factors of Outcomes
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 22 Issue: 7 Year: 2022 Page: 1278-1285
Author(s): Carmelo Tibaldi,Francesca Mazzoni,Vieri Scotti,Enrico Vasile,Daniele Pozzessere,Irene Stasi,Andrea Camerini,Francesca Federici,Giulia Meoni,Chiara Caparello,Marianna Turrini,Virginia Rossi,Lucia Pia Ciccone,Irene Pecora,Beatrice Fantechi,Lorenzo Antonuzzo,Diana Giannarelli,Editta Baldini
A âCrazy Pavingâ Pattern on CT Scan in a Patient Treated with Pembrolizumab
Journal: Current Drug Safety
Volume: 14 Issue: 3 Year: 2019 Page: 242-245
Author(s): Maurizio Marvisi,Sara Ramponi,Laura Balzarini,Chiara Mancini
Occurrence and Severity of Adverse Reactions of Immune CheckpointInhibitors (PD-1 and PD L1) Based on Mordovian Dispensary DataAnalysis
Journal: Current Cancer Therapy Reviews
Volume: 18 Issue: 1 Year: 2022 Page: 51-56
Author(s): Basheer Marzoog
The Current and Evolving Role of Immunotherapy in Metastatic ColorectalCancer
Journal: Current Cancer Drug Targets
Volume: 22 Issue: 8 Year: 2022 Page: 617-628
Author(s): Virgilio S. Silva,Rachel P. Riechelmann,Celso A. Mello
Anti PD-1 and PDL-1 Immunotherapy in the Treatment of Advanced Non- Small Cell Lung Cancer (NSCLC): A Review on Toxicity Profile and its Management
Journal: Current Drug Safety
Volume: 11 Issue: 1 Year: 2016 Page: 62-68
Author(s): Assunta Sgambato, Francesca Casaluce, Paola C. Sacco, Giovanni Palazzolo, Paolo Maione, Antonio Rossi, Fortunato Ciardiello, Cesare Gridelli
PD-L1 Testing for Urothelial Carcinoma: Interchangeability, Reliability and Future Perspectives
Journal: Current Drug Targets
Volume: 22 Issue: 2 Year: 2021 Page: 162-170
Author(s): Thomas Gevaert,Alessia Cimadamore,Rodolfo Montironi,Markus Eckstein
Putting It All Together: Clinical Pearls of Recently Approved Therapies for Triple-Negative Breast Cancer
Ebook: The Management of Metastatic Triple-Negative Breast Cancer: An Integrated and Expeditionary Approach
Volume: 1 Year: 2023
Author(s):
Doi: 10.2174/9789815196023123010007
Assessment of Neurologic Safety Profile of Immune Checkpoint Inhibitors:Evaluation of Adverse Drug Reaction Reports
Journal: Current Drug Safety
Volume: 19 Issue: 3 Year: 2024 Page: 382-394
Author(s): Mandeep Kumar Arora